e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Longitudinal studies of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stage 0 in GOLD does not predict future clinical COPD
J. Vestbo, P. Lange (Hvidovre, Denmark)
Source:
Annual Congress 2002 - Longitudinal studies of COPD
Session:
Longitudinal studies of COPD
Session type:
Oral Presentation
Number:
2548
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Vestbo, P. Lange (Hvidovre, Denmark). Stage 0 in GOLD does not predict future clinical COPD. Eur Respir J 2002; 20: Suppl. 38, 2548
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
GOLD stage 0 and risk of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 352s
Year: 2003
Prediction of the clinical course of COPD using the old and the new GOLD classification
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Is GOLD stage 0 a good predictor of the development of COPD? Preliminary results from the ECRHS II
Source: Eur Respir J 2005; 26: Suppl. 49, 434s
Year: 2005
COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005
Use of quality of life measures and FEF
25-75
to stratify GOLD stage I COPD into stage IA and stage IB
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002
Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
The effect of changing GOLD severity stage on long-term mortality in COPD
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017
Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
The distribution of COPD in general practice using three different GOLD classification
Source: International Congress 2018 – COPD around the world
Year: 2018
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012
Impact of comorbidities on survival of patients with COPD according to GOLD stages
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011
Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept